Harvard announces ExxonMobil Malaria Scholar in Residence

NewsGuard 100/100 Score

The Harvard School of Public Health announced on Thursday that Regina Rabinovich, former director of infectious diseases at the Bill & Melinda Gates Foundation, has been chosen to be the ExxonMobil Malaria Scholar in Residence, "where she will focus on innovative strategies to combat malaria," according to a Harvard press release. "The ExxonMobil Malaria Scholar in Residence program is one of several activities under a new cross-university initiative called 'Defeating Malaria: From the Genes to the Globe,' which aims to produce, transmit and translate knowledge to support the control and ultimate eradication of malaria," the press release states, adding, "Harvard School of Public Health (HSPH), in collaboration with the Harvard Global Health Institute, is spearheading the effort, which is being launched in partnership with the United Nations Special Envoy for Malaria. The ExxonMobil Foundation is funding the one-year residency program" (10/4).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show